Therapeutic Myths in Solid Organ Transplantation Infectious Diseases-Reference-Cited by-同舟云学术

Therapeutic Myths in Solid Organ Transplantation Infectious Diseases

Published:2024-06-15 Issue:7 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Goodlet Kellie J¹^ORCID,McCreary Erin K²,Nailor Michael D³,Barnes Darina⁴,Brokhof Marissa M⁵,Bova Sarah⁶,Clemens Evan⁷,Kelly Beth⁸,Lichvar Alicia⁹,Pluckrose Dawn M¹⁰,Summers Bryant B¹¹,Szempruch Kristen R¹²,Tchen Stephanie¹³

Affiliation:

1. Department of Pharmacy Practice, Midwestern University , Glendale, Arizona , USA

2. Department of Medicine, Division of Infectious Diseases, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania , USA

3. Department of Pharmacy Services, St Joseph's Hospital and Medical Center , Phoenix, Arizona , USA

4. Department of Pharmacy, Comprehensive Transplant Center, Cedars Sinai Medical Center , Los Angeles, California , USA

5. Department of Pharmacy, Rush University Medical Center , Chicago, Illinois , USA

6. Department of Pharmacy, University of Maryland Medical Center , Baltimore, Maryland , USA

7. Department of Pharmacy, University of Washington Medical Center , Seattle, Washington , USA

8. Department of Pharmacy, Indiana University Health , Indianapolis, Indiana , USA

9. Center for Transplantation, UC San Diego Health , San Diego, California , USA

10. Department of Pharmacy, Tufts Medical Center , Boston, Massachusetts , USA

11. Comprehensive Transplant Center, The Ohio State University Wexner Medical Center , Columbus, Ohio , USA

12. Department of Pharmacy, University of North Carolina Medical Center , Chapel Hill, North Carolina , USA

13. Department of Pharmacy, Froedtert Hospital , Milwaukee, Wisconsin , USA

Abstract

Abstract Infection management in solid organ transplantation poses unique challenges, with a diverse array of potential pathogens and associated antimicrobial therapies. With limited high-quality randomized clinical trials to direct optimal care, therapeutic “myths” may propagate and contribute to suboptimal or excessive antimicrobial use. We discuss 6 therapeutic myths with particular relevance to solid organ transplantation and provide recommendations for infectious diseases clinicians involved in the care of this high-risk population.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae342/58241200/ofae342.pdf

Reference104 articles.

1. Top myths of diagnosis and management of infectious diseases in hospital medicine;Johnson;Am J Med,2022

2. Antibiotic myths for the infectious diseases clinician;McCreary;Clin Infect Dis,2023

3. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort;Vidal;Transpl Infect Dis,2012

4. The challenge of urinary tract infections in renal transplant recipients;Hollyer;Transpl Infect Dis,2018

5. Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice;Goldman;Clin Transplant,2019